By John Ballard
...Sakuda learned of a study being conducted by Charles Grob, a psychiatrist and researcher at Harbor-U.C.L.A. Medical Center who was administering psilocybin � an active component of magic mushrooms � to end-stage cancer patients to see if it could reduce their fear of death. Twenty-two months before she died, Sakuda became one of Grob�s 12 subjects. When the research was completed in 2008 � (and published in the Archives of General Psychiatry last year) � the results showed that administering psilocybin to terminally ill subjects could be done safely while reducing the subjects� anxiety and depression about their impending deaths.
The article is nearly four thousand words long. Go read it and make up your own commentary.